MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
TechWerks, LLC (technologywerks) (SDVOSB)
San Antonio, Texas
2026: OPMED 2026_Operational Medicine (OpMed) SYMPOSIUM & TECHNOLOGY SHOWCASE March 17-18 2026, San Antonio, Texas
Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. (HJF)
Organization & Developments: HJF (Henry M. Jackson Foundation)
HJF: Locations
Japan
Industry: Japan
Qualipse
Parents
2026: Japan Approves the World’s First Treatment Made With Reprogrammed Human Cells
Architects: Biotechnology_Stem Cell Therapeutics
Architects: Cardiovascular, Cardiac & Cardiology Companies _ Pharmaceutical & Biotechnology
Industry: Japan
Children
*It's a sheet of specialized heart cells called cardiomyocytes differentiated from iPS cells of healthy donors, and it generated considerable buzz when it was presented at the Osaka-Kansai Expo.
*It's intended for patients with severe heart failure due to ischemic cardiomyopathy who don't recover sufficiently despite standard treatment, including drug therapy and invasive procedures.
*One of the regenerative medicine products that has been approved is ReHeart, from Qualipse, a startup based at Osaka University.
2023: Qualips targets approval of cardiomyocyte cell sheets derived from heterologous iPS cells – window-to-japan.eu
Jumps
Osaka University